0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV467.54%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.48Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Chimerix Stock Discussion
$Tonix Pharmaceuticals (TNXP.US)$
Investors are buying up shares of vaccine producers, antiviral drug makers, and protective equipment companies, hoping to profit as they did during the coronavirus pandemic.
Bavarian Nordic, the only producer approved of the pox vaccine, saw its shares jump 16.5% on the day in...
📊⚡️📊
Phase I dose escalation trials continue at the National Institutes of Health (NIH) and the Pacific Pediatric Neuro-Oncology Consortium (PNOC) in adult and pediatric CNS tumor patients, respectively. The dose escalation trials are currently dosing at a...
This is all I need to hold and/or buy more on dips
"..Turning to clinical outcomes. The survival of H3 K27-mutant glioma patients who received ONC201 in the frontline setting following radiotherapy, which I'll notice the same setting of the ACTION trial was reported as 21.7 months from diagnosis in contrast to 12 months for patients who did not receive ONC201. Favorable survival outcomes among ONC201 treated patients were consistently observed across a variety of sensitivity ...
No comment yet